Prognos Blog
Reflections on the PMSA Winter Symposium
By Theresa Greco, Chief Commercial Officer The PMSA Winter Symposium, “Innovation in Analytics via Machine Learning & AI” brought together...
The Value of Using Lab Data
By Heather Von Allmen Arthur Conan Doyle’s ubiquitous fictional detective Sherlock Holmes once said, “It is a capital mistake to...
HbA1c scores influence HCPs’ therapy choices
Diabetes is one of many conditions where lab testing plays a critical role. Healthcare providers (HCPs) order lab testing, in...
Optimizing Oncology Sales and Marketing with Lab Data
Rather than prescribing every cancer patient the same treatment regimen, oncologists and other interdisciplinary members of a patient’s care team...
5 ways to optimize sales force efficiency with lab data and AI
As a life sciences brand manager, you are likely always looking to refine your sales and marketing strategies. You need...
Diabetes and RA: Further Explanations for Comorbidity
Why, how, and what might be next? By Jason Bhan, MD, Fernando Schwartz, PhD, and Lauren Wiener If you’ve been...
Comorbidity Between Diabetes and RA
How is comorbidity affected by a double positive? By Jason Bhan, MD, Fernando Schwartz, PhD, and Lauren Wiener> If you...
Diabetes and Rheumatoid Arthritis: A Missing Link?
Is there an unidentified link between diabetes and RA? By Jason Bhan, MD, Fernando Schwartz, PhD, and Lauren Wiener Diabetes...
5 Ways Life Science Brands Are Putting AI to Work
Healthcare AI delivers actionable insights to pharma companies by recognizing key trends and patterns useful for finding population segments that...
What’s Next in Pancreatic Cancer Screening
What Prognos Found and Where We’ll Take It By Jason Bhan, MD, Fernando Schwartz, Brian Saindon, & Lauren Wiener Over...